CMS NEWS
FOR IMMEDIATE RELEASE
July 2, 2019
Contact: CMS Media
Relations
(202) 690-6145 | CMS Media Inquiries
CMS Expands Coverage of Ambulatory Blood Pressure Monitoring
(ABPM)
Decision increases access by extending Medicare coverage to additional diagnostic applications
Today the Centers for
Medicare & Medicaid Services (CMS) finalized its national coverage policy
for Ambulatory Blood Pressure Monitoring (ABPM). ABPM is a non-invasive
diagnostic test that uses a device to track blood pressure over 24-hour
cycles, allowing a doctor to assess a patient’s blood pressure during routine
daily living, instead of when they are sitting nervously on an examination
table. ABPM may measure blood pressure more accurately and lead to the
diagnosis of high blood pressure in patients who would not otherwise have
been identified as having the condition.
“CMS is dedicated to
improving cardiovascular health in the Medicare population,” said CMS Administrator
Seema Verma. “Today’s decision reflects CMS’ commitment to continually
updating our policies to ensure that more Medicare beneficiaries have access
to the latest technology and appropriate evidence-based health care. We
believe stakeholders will appreciate the policy being expanded to include
diagnostic uses recommended by the multi-society task force blood pressure
practice guidelines.”
CMS received a request
from stakeholders to reconsider this national coverage determination.
Prior to today, ABPM was covered only for those patients with suspected
“white coat hypertension” under specific conditions. White coat
hypertension occurs when a patient’s anxiety from being in a clinical setting
causes an increase in blood pressure beyond what occurs outside the clinical
setting. Consistent with multi-society professional guidelines, today’s
decision expands access to ABPM to include coverage for cases of suspected
“masked hypertension,” which is essentially the opposite of white coat hypertension
and occurs when blood pressure measurements in a doctor’s office are lower
than measurements taken outside a doctor’s office.
In addition, today’s
decision lowers the blood pressure threshold for hypertension from the
current policy of 140/90 down to 130/80 to align with the latest society
recommendations regarding the diagnostic criteria. This will allow more
patients to use ABPM and receive appropriate treatment if needed.
To read the decision,
visit the CMS website at: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=294
###
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS
Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.
|
|
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, July 2, 2019
CMS Expands Coverage of Ambulatory Blood Pressure Monitoring (ABPM)
Subscribe to:
Post Comments (Atom)


No comments:
Post a Comment